Related Experiment Video

Updated: Jun 14, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

Effects of tyroservatide on histone acetylation in lung carcinoma cells

Qiong Xu1, Rong Lu, Zhi-Feng Zhu

  • 1Department of Immunology, Tianjin Medical University, Tianjin, China.

International Journal of Cancer
|March 24, 2010
PubMed

Insights

Tyroservatide (YSV) effectively combats lung carcinoma by inhibiting histone deacetylase (HDAC) activity. This mechanism halts tumor cell proliferation and induces cell cycle arrest, suggesting YSV

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Tyroservatide (YSV) is a low-molecular weight polypeptide with demonstrated antitumor effects.
  • Previous studies indicated YSV's efficacy against experimental hepatocarcinoma and lung carcinoma.

Purpose of the Study:

  • To investigate the effects of Tyroservatide (YSV) on human lung carcinoma cell lines.
  • To elucidate the antitumor mechanism of YSV, focusing on its impact on histone acetylation.

Main Methods:

  • Exposure of human lung carcinoma cell lines (A549, NCIH460, NCIH292, NCIH1299) to YSV.
  • Assessment of cell proliferation, cell cycle distribution, and protein/mRNA levels of p21 and p27.
  • Measurement of histone deacetylase (HDAC) activity and histone acetylation levels (H3, H4) in total and gene-specific chromatin.

Main Results:

  • YSV significantly inhibited the proliferation of all tested human lung carcinoma cell lines.
  • YSV induced G(0)/G(1) cell cycle arrest and increased p21 and p27 expression.
  • YSV inhibited HDAC activity, leading to increased histone H3 and H4 acetylation, particularly in p21 gene regions.

Conclusions:

  • YSV exhibits potent antitumor effects on human lung carcinoma.
  • The mechanism involves HDAC inhibition, leading to enhanced histone acetylation, p21 upregulation, and cell cycle arrest.
  • YSV demonstrates potential as a therapeutic agent for lung carcinoma.

More Related Videos

Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN11:50

Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN

Published on: April 3, 2026

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS09:20

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on: August 10, 2017

Related Concept Videos

Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3 variants are also...
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...